Deputy president William Ruto Surprised many Kenyans after He went against The odds and Took Russian made Sputnik Vaccine. His Boss Uhuru Kenyatta was injected with Atrazeneca One.
However, The Government moved with Speed and Banned the importation, Distribution and Administration of Covid19 Vaccine By Private players hence Allowing The Ministry of Health to take Full control of the Exercise.
Today The worrying updates indicates that Argentina President has tested Positive For Coronavirus Nearly Two months after He was injected with Russian Made Sputnik V Vaccine. The Latin Based country has been experienced surge in cases recently.
It should be known that Argentina was the first country after Russia to use The vaccine. The jab boosts of 91.6% efficacy and Protects against severe variants of the Global Pandemic
With Such updates The faith in the dose will lower considering that The head of state has such high medical attention.
Content created and supplied by: MJcreativez (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More